Objective: To characterize patient and programmatic factors associated with retention in care
during the pre-antiretroviral therapy (ART) period and linkage to ART care. Design …

Objectives To assess the proportion of patients lost to programme (died, lost to follow‐up,
transferred out) between HIV diagnosis and start of antiretroviral therapy (ART) in sub …

Background Prognostic models have been developed for patients infected with HIV-1 who
start combination antiretroviral therapy (ART) in high-income countries, but not for patients in …

Introduction: Increasingly, there is a need for health authority scale up of successfully piloted
differentiated models of antiretroviral therapy (ART) delivery. However, there is a paucity of …

Background: HIV/AIDS has historically had a sex and gender-focused approach to
prevention and care. Some evidence suggests that HIV-positive men have worse treatment …

Background Antiretroviral therapy (ART) has been scaled-up rapidly in Africa. Programme
reports typically focus on loss to follow-up and mortality among patients receiving ART …

Introduction Multimorbidity is a growing concern worldwide, with approximately 1 in 4 adults
affected. Most of the evidence on multimorbidity, its prevalence and effects, comes from high …

Objectives: To determine retention in HIV care for individuals not yet eligible for antiretroviral
therapy (ART) and to explore factors associated with retention in a rural public health HIV …

Objective: To investigate antiretroviral treatment (ART) interruption in a long-term treatment
cohort in South Africa. Methods: All adults accessing ART between 2004 and 2009 were …

Methods: PubMed, Embase, Psycinfo and Cochrane were searched for studies that report
on potential risk factors for LTFU in adults who initiated ART in LMICs. Meta-analysis was …